2026 EARLY CONFIRMED SPEAKERS

BRIAN DEAN ABRAMSON is a leading expert on vaccine law, and was the founding chair of the National Vaccine Law Conference. He teaches the subject as adjunct professor of vaccine law at the Florida International University College of Law, and at the University of Houston Law Center. He is the...

Dr. Qaiser Akram is a distinguished veterinarian and microbiologist dedicated to advancing animal and human health through innovative research and education. As an Assistant Professor in the Department of Pathobiology at the University of Veterinary and Animal Sciences, Lahore, Pakistan, Dr. Akram...

Hansilla Alaigh is the Founder and CEO of Global Action Alliance, an AI tech company pioneering the next generation of strategic intelligence. With 14+ years in biotech and pharma leadership, she drives R&D strategy and stakeholder management across medical devices, vaccines, and...

Raiees Andrabi is an Associate Professor of Medicine, Perelman School of Medicine, Division of Infectious Diseases, Department of Medicine, University of Pennsylvania. Raiees Andrabi earned his PhD degree from the All India Institute of Medical Sciences in Biochemistry and performed his...

Dr. Navneet Bichha is a physician scientist from Nepal with a strong foundation in clinical medicine and public health, with a decade experience in vaccine research, policy implementation, and global health partnerships.  He currently serves as a Senior Program Officer at The INCLEN Trust...

Dr. Enrique Chacon-Cruz.Mexican-born medical doctor with a degree from Universidad Autonoma de Guadalajara, Mexico, and further specializations in Pediatrics and Infectious Diseases from the National Institute of Pediatrics in Mexico City, and the Eastern Virginia Medical School in...

Grace Chen is a Principal Scientist at Merck, known for vaccine analytical research & development and process improvement using computer technology. With over 20 years of experience in the pharmaceutical industry, she is a patent holder and peer-reviewed author of multiple manuscripts. She has...

Dr. Ghania Chikh, Senior Director, Vaccine Development, brings extensive experience to her senior leadership role at Acuitas Therapeutics, Inc. Dr. Chikh has spent much of her career working with vaccines and lipid nanoparticle (LNP) delivery technology. In fact, her PhD thesis was focused on...

Wayland Coker, currently serves as the Chief Supply Chain Strategist at HHS/ASPR, and the Director of the Supply Chain Optimization office within the Center for Industrial Base Management & Supply Chain. More recently he was named ASPR’s White House liaison for all medical and pharmaceutical...

Tonya Colpitts is an accomplished professional with a proven track record in the global vaccine industry. Currently serving as Associate Vice President and Global Project Head for Vaccines at Sanofi, Tonya brings a wealth of experience and expertise to her role. With a strong background in research ...

Renée DiResta is a social media researcher and the author of Invisible Rulers: The People Who Turn Lies into Reality. She studies adversarial abuse online, ranging from state actors running influence operations, to spammers and scammers, to issues related to child safety. In October 2024, she...

Dr. Rikhav Gala is a pharmaceutical scientist with extensive expertise in vaccine research, drug development, and advanced formulations. He holds a Ph.D. and M.Sc. in Industrial Pharmaceutical Sciences and currently leads innovation programs at Pfizer, where his work focuses on translating...

Pascal Geldsetzer is an Assistant Professor of Medicine at Stanford University and a Chan Zuckerberg Biohub Investigator. He has won an NIH New Innovator Award to investigate the feasibility of applying causal effect estimation techniques from the social sciences to clinical research questions. As...

Dr. Susan Gerber is Senior Medical Director, Adult and Respiratory Viral Vaccines, US Medical Affairs, GSK.  Before joining GSK, Dr. Gerber was at the Centers for Disease Control and Prevention where she served as Associate Director of Antimicrobial Resistance in the Division of...

Professor Michael Good is a Principal Research Leader at the Institute for Biomedicine and Glycomics, Griffith University, Australia.  He heads the Laboratory of Vaccines for the Developing World.  He has developed candidate vaccines for the prevention of malaria and streptococcus and these have...

Dr. Raymond P. Goodrich is a distinguished biomedical researcher and innovator with over 37 years of experience in transfusion medicine, pathogen reduction technologies, and immunotherapy. He is a tenured professor in the Department of Microbiology, Immunology, and Pathology at Colorado State...

Dr. Girija Goyal is an immunologist working with the organs-on-chips and diagnostics platforms to design better in vitro models of the human immune system to develop new immunotherapeutics and derisk vaccines. Her research has reached the real world as these in vitro models are now used at...

Trained as a biochemist at the Johns Hopkins University, the US National Institutes of Health and Duke University, Bill Hausdorff’s vaccine career started at the US Agency for International Development and Centers for Disease Control in Washington DC and Cairo, Egypt, where he worked to catalyze...

Jon Heinrichs is Vice President and head of Discovery Science at IAVI, based in New York City. His responsibilities include advancing broadly neutralizing antibodies for HIV prevention and leading IAVI’s three laboratories, based in La Jolla, CA, Jersey City, NJ, and New Delhi, India. Prior to...

Tim is the Chairman & CEO of GPN Vaccines. He has extensive expertise in the life sciences, executive management and venture capital investment. Tim was previously CEO of ANU Connect Ventures, a $30M pre-seed VC fund, the Deputy Vice Chancellor for Research & Innovation at The University of ...

After 11 years as a veterinary practitioner, Alasdair King joined the pharmaceutical industry.  He has taken many roles including technical adviser, pharmacovigilance manager, and government liaison.  He has been responsible for the development of avian influenza vaccine banks and led the company...

Holger Kissel Holger Kissel, Ph.D., serves as Senior Vice President Scientific Relations & Liaison at BioNTech. Being a part of the Company since 2013, he assumed this role in 2023. With an extensive background in business development and licensing, he is dedicated to advancing global health...

Tom Mahoney is an experienced investor and philanthropist in the field of Immunology and Infectious Diseases, currently affiliated with the Harvard T.H. Chan School of Public Health Department of Immunology and Infectious Diseases. Tom's work is characterized by a deep commitment to public...

Stephanie Oestreich is Managing Director of the Myeloma Investment Fund (MIF) and is the chair of the McCloy Alumni Association. She is also on the faculty of MIT, a member of SpringBoard Ventures, an advisor at grIP Venture Studio, to Biognosys (a Bruker company), Invitris, CART company CelineTx...

Tyler Sandberg is a scientist holding a PhD in vaccine immunology from the Karolinska Institute and a master’s degree in immunology and infection biology from Uppsala University. His doctoral research involved conducting several vaccine studies to examine human immune responses to various...

Dr. Alessandro Sette devoted more than 40 years to understand and measure immune responses. He co-authored more than 1,000 peer reviewed articles and has an H-factor of 195. Dr Sette focus is to characterize beneficial  immune responses (for example fighting infection), as opposed to immune...

Victoria Standley is an experienced healthcare professional and public health advocate with over 18 years in service and leadership roles. She currently serves as an Immunization Program Specialist at Sanford Health, a large nonprofit health system serving 2.4 million patients across the Upper...

Senior Scientific Officer, Concept Acceleration Program (CAP) – Vaccines, NIAID/DMID/OBRRTR Dr. Taylor has >25 years of experience in vaccine development and spent for several years in the biotech industry working on bacterial vaccines and monoclonal antibodies from discovery through Phase...

Richard White is a Prof in Infectious Disease Epidemiology in the TB Modelling Group, TB Centre, Vaccine Center and Math Modelling Centre at the London School of Hygiene and Tropical Medicine. He was awarded a PhD in infectious disease modelling in 2006, led the establishment of the LSHTM’s Centre...